DHA

Pajjiż: Awstralja

Lingwa: Ingliż

Sors: Department of Health (Therapeutic Goods Administration)

Ingredjent attiv:

docosahexaenoic acid (DHA)-rich oil derived from microalgae Schizochytrium sp., Quantity: 375 mg (Equivalent: docosahexaenoic acid, Qty 150 mg)

Disponibbli minn:

Ferngrove Pharmaceuticals Australia Pty Ltd

Għamla farmaċewtika:

Capsule, soft

Kompożizzjoni:

Excipient Ingredients: modified food starch; purified water; glycerol

Rotta amministrattiva:

Oral

Indikazzjonijiet terapewtiċi:

Helps maintain/support healthy eye development ; Maintain/support healthy eye function ; Maintain/support eye health ; Helps enhance/promote general health and wellbeing ; Maintain/support general health and wellbeing ; Maintain/support cardiovascular system health ; Maintain/support brain function ; Maintain/support brain health ; Maintain/support nervous system health ; Maintain/support brain/central nervous system development ; Maintain/support nervous system function ; Helps maintains/support healthy foetal CNS/brain development

Sommarju tal-prodott:

Visual Identification: ;

L-istatus ta 'awtorizzazzjoni:

Listed

Data ta 'l-awtorizzazzjoni:

2021-06-03